Cargando…
Evaluation of the Access Bio CareStart rapid SARS-CoV-2 antigen test in asymptomatic individuals tested at a community mass-testing program in Western Massachusetts
Point-of-care antigen-detecting rapid diagnostic tests (RDTs) to detect Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) represent a scalable tool for surveillance of active SARS-CoV-2 infections in the population. Data on the performance of these tests in real-world community settings a...
Autores principales: | Suliman, Sara, Matias, Wilfredo R., Fulcher, Isabel R., Molano, Francisco J., Collins, Shannon, Uceta, Elizabeth, Zhu, Jack, Paxton, Ryan M., Gonsalves, Sean F., Harden, Maegan V., Fisher, Marissa, Meldrim, Jim, Gabriel, Stacey, Franke, Molly F., Hung, Deborah T., Smole, Sandra C., Madoff, Lawrence C., Ivers, Louise C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9734130/ https://www.ncbi.nlm.nih.gov/pubmed/36494424 http://dx.doi.org/10.1038/s41598-022-25266-3 |
Ejemplares similares
-
Performance and Operational Evaluation of the Access Bio CareStart Rapid Antigen Test in a High-Throughput Drive-Through Community Testing Site in Massachusetts
por: Pollock, Nira R, et al.
Publicado: (2021) -
396. Disparities in SARS-CoV-2 Antibody Prevalence: Findings from a Citywide Serosurvey in Holyoke, Massachusetts, November 2020–January 2021
por: Matias, Wilfredo, et al.
Publicado: (2021) -
Disparities in SARS-CoV-2 Infection by Race, Ethnicity, Language, and Social Vulnerability: Evidence from a Citywide Seroprevalence Study in Massachusetts, USA
por: Matias, Wilfredo R., et al.
Publicado: (2023) -
Assessment of CareStart G6PD rapid diagnostic test and CareStart G6PD biosensor in Mauritania
por: Djigo, Oum Kelthoum Mamadou, et al.
Publicado: (2021) -
Laboratory evaluation of immunochromatographic rapid diagnostic tests for cholera in Haiti
por: Matias, Wilfredo R., et al.
Publicado: (2017)